About Us
Aeon Respire's founders are bringing their extensive expertise in respiratory medicine to advance a better approach to achieve long-lasting and robust breathing health for millions. The company is advancing a novel  inhaled drug that effectively blocks the source of pathologic calcium signaling in the lungs. This represents a new approach to treating severe asthma and other lung diseases and is differentiated by a unique mechanism of action. Aeon Respire's lead program AR-001 holds promise to address unmet need and disrupt existing treatments in large markets and to achieve blockbuster status.

Aeon Respire

Org chart

Teams

Offices